Inotiv (NOTVQ) Asset Writedowns and Impairment (2010 - 2026)
Inotiv's (NOTVQ) quarterly Asset Writedowns and Impairment came in at $21000.0 in Q1 2026, up 104.02% YoY from $10293.0 in Q1 2025, and down 94.52% on a QoQ basis from $383000.0 in Q4 2025.
Inotiv (NOTVQ) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Inotiv (NOTVQ) has 15 years of Asset Writedowns and Impairment data on file, last reported at $21000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 104.02% year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $887000.0 (up 231.99% YoY) and the FY2025 annual result came in at -$492000.0, down 948.28% from the prior year.
- Asset Writedowns and Impairment fell to $21000.0 in Q1 2026, from $383000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.3 million in Q3 2024 to a low of -$1.0 million in Q2 2024.
- A 5-year average of $149941.2 and a median of $255000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment jumped 1372.73% — and 2025, when it sank 370.47%.
- Tracing NOTVQ's Asset Writedowns and Impairment over 5 years: stood at $1.1 million in 2022, then plunged by 140.63% to -$438000.0 in 2023, then dropped by 3.42% to -$453000.0 in 2024, then soared by 184.55% to $383000.0 in 2025, then tumbled by 94.52% to $21000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $21000.0 (Q1 2026), $383000.0 (Q4 2025), and -$41000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | 524,000.00 |
| Jun 30, 2025 | 524,000.00 |
| Mar 31, 2025 | -522,000.00 |
| Mar 31, 2025 | -522,000.00 |
| Dec 31, 2024 | -453,000.00 |
| Dec 31, 2024 | -453,000.00 |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | -438,000.00 |
| Dec 31, 2023 | -438,000.00 |